NCT01929343View on ClinicalTrials.gov

Lidocaine Infusion as a Treatment for Cocaine Relapse and Craving

PHASE2CompletedINTERVENTIONAL
Enrollment

84

Participants

Timeline

Start Date

January 31, 2014

Primary Completion Date

March 31, 2016

Study Completion Date

March 31, 2016

Conditions
Cocaine Addiction
Interventions
DRUG

lidocaine following cue-induced craving

as described in Arm Description

DRUG

lidocaine following neutral stimulus

as described in Arm Description

DRUG

saline

as described in Arm Description

Trial Locations (1)

75390-8564

UT Southwestern Medical Center at Dallas, Division on Addictions, Dallas

All Listed Sponsors
collaborator

National Institute on Drug Abuse (NIDA)

NIH

lead

Bryon Adinoff

OTHER

NCT01929343 - Lidocaine Infusion as a Treatment for Cocaine Relapse and Craving | Biotech Hunter | Biotech Hunter